Neurosciency Friday: thalidomide, decision-making, nanobots, and more

It’s time for this week’s installment of Neurosciency Friday (inspired by NPR Science Friday!), in which I bring you science news and tidbits from around the web!

The New York Times recounts the fascinating and tragic history of the drug thalidomide, which was not approved in the US thanks to the efforts of a persistent FDA scientist.

A new study suggests that adolescents aren’t the only age group who makes bad decisions.

Popular Science has banned commenting on their website because “it can be bad for science.”  I guess I agree.  Commenters on news websites are not really known for their use of facts and logic.  Actually, though, there’s a lot of fun stuff on the PopSci website this week:

Are you a scientist trying to get cited by other researchers?  This study says you should share your data publicly.

How the government shutdown impacts science.

Have a great weekend!

Advertisements

One thought on “Neurosciency Friday: thalidomide, decision-making, nanobots, and more

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s